
Anthropic’s founders seek voting control ahead of IPO
Anthropic is asking its shareholders to approve a structure that would give its seven co-founders a combined 50.1% of the vote on most corporate matters.
Anthropic's founders are seeking shareholder approval for a special share structure that would give CEO Dario Amodei and his six co-founders combined voting control of 50.1% on most corporate matters once the company goes public, provided at least three of them maintain a minimum stake. The founders own only 2% of the company each and have pledged to give away 80% of their wealth, so these new shares carry no extra economic value but preserve their control after the IPO. Super-voting shares are not new, having been used by other tech leaders to maintain control of their companies, though the group approach here is unusual. The arrangement includes additional checks: Anthropic's Long-Term Benefit Trust would still choose most board members, the founders' board seats would increase from two to three, and employees would receive stock to break ties on certain issues.
- Anthropic reportedly prices IPO at $83 a share, above projected range · TechCrunch
- Amazon and Google will together own nearly 30% of Anthropic after its IPO · TechCrunch
- Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials · TechCrunch
- All of today’s AI news, biggest first →
One short email a day with the stories that matter. Free. Unsubscribe with one click.
Want to go deeper than the news? Explore live, cohort-based AI courses taught by practitioners.
Browse AI courses on Maven
Anthropic reportedly prices IPO at $83 a share, above projected range
The long-awaited IPO reportedly values the company at $1.5 trillion on a fully diluted basis.
Also reported by Crunchbase News and SiliconANGLE

Amazon and Google will together own nearly 30% of Anthropic after its IPO
Amazon will own just under 15% of Anthropic after the IPO, with the option to go much higher. Google is a close second with holdings of nearly 14%.
Also reported by Crunchbase News

Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.
Also reported by SiliconANGLE

Genesis AI Raises $500M At $3.5B Valuation To Bring Its Robots To Factories And Warehouses
Genesis AI, a startup teaching robots to perform physical tasks by learning from human movements, announced Tuesday it has raised $500 million in Series A funding at a $3.5 billion valuation. Premji Invest, Khosla Ventures and Eclipse co-led the round, which brings the company’s disclosed funding to $605 million since its 2024 inception. Genesis previously raised $105 million in a round announced in July 2025. The company is developing both robots and the AI software that controls them. Its appr

Agile Robots raises $500M to increase production capacity
Agile Robots’ Agile ONE humanoid moving between workstations. | Source: Agile Robots Agile Robots has raised $500 million in Series F funding. This brings the company’s valuation to $8.5 billion and total funding raised to $2 billion. Agile Robots builds and deploys a range of robots, including humanoids, mobile robots, robotic arms, and robotic hands. It also builds the software and AI models behind these robots. The company’s customers include leaders in the automotive, consu

Anthropic’s compute spending is increasing by 4x per year, outpacing OpenAI’s 3x
Anthropic spent nearly $10 billion on compute and infrastructure in the third quarter of 2026, or close to $40 billion on an annualized basis, up from just $433 million in 2023.